GeneDx Holdings Corp. Files 8-K on Security Holder Votes & Financials
Ticker: WGSWW · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1818331
| Field | Detail |
|---|---|
| Company | Genedx Holdings Corp. (WGSWW) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, filing
TL;DR
GeneDx filed an 8-K for security holder votes and financials. Keep an eye on this.
AI Summary
On June 18, 2025, GeneDx Holdings Corp. filed an 8-K report detailing a submission of matters to a vote of security holders and financial statements. The company, formerly known as Sema4 Holdings Corp. and CM Life Sciences, Inc., is incorporated in Delaware and headquartered in Stamford, Connecticut.
Why It Matters
This filing indicates important corporate actions and financial reporting, which could impact investor decisions and the company's strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate events and financial statements, not indicating immediate financial distress or significant operational changes.
Key Numbers
- 001-39482 — Commission file number (SEC filing identifier)
- 85-1966622 — I.R.S. Employer Identification No. (Company tax identification)
Key Players & Entities
- GeneDx Holdings Corp. (company) — Registrant
- Sema4 Holdings Corp. (company) — Former company name
- CM Life Sciences, Inc. (company) — Former company name
- June 18, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Stamford, Connecticut (location) — Principal executive office address
FAQ
What specific matters were submitted to a vote of security holders?
The filing states 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' item?
This indicates that the company is providing updated financial information and supporting documents as part of this report.
When did GeneDx Holdings Corp. change its name from Sema4 Holdings Corp.?
The date of the name change from Sema4 Holdings Corp. was July 21, 2021.
What is the company's principal executive office address?
The principal executive office is located at 333 Ludlow Street, North Tower, 6th Floor, Stamford, Connecticut 06902.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding GeneDx Holdings Corp. (WGSWW).